Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal
Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today.
Why Caris Life Sciences (CAI) stock is down today as biotech slips
Caris Life Sciences shares were down about 1.8% at $27.44 as of 2:41 p.m. ET, after trading between $27.00 and $27.97 during Tuesday’s session.